✨ Education and Health Notices
NEW ZEALAND GAZETTE, No. 47 — 4 MAY 2017
Pursuant to section 10 of the Private Schools Conditional Integration Act 1975, notice is given that the supplementary integration agreement has been signed between the Minister of Education on behalf of her Majesty The Queen, acting through the Group Manager, Schools and Student Support, Ministry of Education, pursuant to delegated authority, and the proprietors of the following school:
443 Hastings Christian School, Hastings
The said supplementary integration agreement was executed on 27 April 2017.
A copy of the supplementary integration agreement is available for inspection without charge by any member of the public via the following email address: enquiries.napier@education.govt.nz.
Dated at Wellington this 27th day of April 2017.
JIM GREENING, Group Manager, Schools and Student Support, Ministry of Education.
2017-go2120
Notice of Approval Given Pursuant to Section 160(3) of the Crown Entities Act 2004
Pursuant to section 160(3) of the Crown Entities Act 2004, I, Jeremy Salmond, Treasury Solicitor, hereby give notice that on 23 April 2017 the Honourable Steven Joyce, Minister of Finance, and the Honourable Dr Jonathan Coleman, Minister of Health, gave approvals, under section 160(1)(b) of the Crown Entities Act 2004, in relation to section 162 of that Act, for New Zealand Health Partnerships Limited to borrow from Westpac New Zealand Limited.
Dated at Wellington this 1st day of May 2017.
JEREMY SALMOND, Treasury Solicitor.
2017-go2122
Notice of Application to Register a Trade Name Product (Notice No. MPI 746)
Maree Zinzley, Manager Approvals Operations of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 ("Act"), that the following application has been made to register a trade name product under section 9(1) of the Act:
Trade Name: ProZinc Insulin Injection for Cats
Reference: A011421-01
Active Ingredient and Concentration:
Human insulin 40IU/mL per 10mL vial
Formulation Type: Aqueous solution
General Use Claim:
For the treatment of diabetes mellitus in cats to achieve reduction of hyperglycaemia and improvement of associated clinical signs.
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
a. must state in full the reasons for making the submission;
b. may state any decision sought on that application; and
c. must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
a. where submissions on this application are to be sent;
b. where requests for copies of the public information relating to the application can be sent;
44
Next Page →
NZ Gazette 2017, No 47
✨ LLM interpretation of page content
🎓 Supplementary integration agreement for Hastings Christian School
🎓 Education, Culture & Science27 April 2017
Private Schools, Conditional Integration, Hastings Christian School
- Jim Greening, Group Manager, Schools and Student Support, Ministry of Education
💰 Approval for New Zealand Health Partnerships to borrow
💰 Finance & Revenue1 May 2017
Crown Entities Act, Borrowing Approval, Health Partnerships
- Jeremy Salmond, Treasury Solicitor
- Honourable Steven Joyce, Minister of Finance
- Honourable Dr Jonathan Coleman, Minister of Health
🌾 Application to register ProZinc Insulin Injection for Cats
🌾 Primary Industries & ResourcesTrade Name Registration, Agricultural Compounds, Veterinary Medicines, ProZinc Insulin
- Maree Zinzley, Manager Approvals Operations, Ministry for Primary Industries